Healthcare Industry News: Insulet
News Release - March 23, 2006
Insulet Corporation Names Ruthann DePietro Vice President of Quality and Regulatory AffairsBEDFORD, Mass., March 23 (HSMN NewsFeed) -- Ruthann DePietro has joined Insulet Corporation as Vice President of Quality and Regulatory Affairs. Insulet manufactures the OmniPodŽ Insulin Management System, an innovative new product for the treatment of diabetes that brings together safe, reliable, continuous subcutaneous insulin infusion and blood glucose monitoring in an easy-to-use, two-part system.
In addition to qualifying Insulet's automated manufacturing later this spring, DePietro's chief responsibilities will include overseeing the company's quality assurance program and developing and administering quality processes throughout the organization. She will also ensure compliance with regulatory, accreditation, and legislative standards, including those related to the development of the next generation of OmniPod systems.
In announcing the appointment, Duane DeSisto, Insulet Corporation President and CEO, noted, "Ruthann DePietro's career path has included R&D, manufacturing, engineering, quality and regulatory supervision. She brings to our team more than 15 years of experience as a senior quality control and regulatory compliance manager within the medical device industry. We value her experience and look forward to her contributing to our firm's continued growth, evolution, and stability."
"I am thrilled to join the team at Insulet," DePietro said. "With the recent U.S. commercial introduction of the OmniPod Insulin Management System, Insulet has positioned itself to become a major player in the diabetes marketplace. I am truly excited at the prospect of helping to ensure the quality of such an innovative, vital diabetes treatment."
Immediately prior to joining Insulet, DePietro served as Vice President of Quality and Regulatory Compliance at ONUX Medical, Inc., the developer of laparoscopic suturing and fixation devices and accessories for general surgery, plastic surgery, cardiology and cardiovascular products. Before that, she worked in quality assurance and engineering management at Micro Med, Inc. / Disetronic, a contract manufacturer of medical devices related to infusion sets, arthroscopy, orthopedic, urology, cardiology, and insulin delivery products. Her earlier career included service with C.R. Bard, Inc. and Mallinckrodt Medical, Inc., with continuing emphasis on total quality management (TQM) systems.
DePietro earned a B.S. in Polymer Chemistry from the University of Rochester and an M.B.A. in High Tech Business from Northeastern University. She resides in Atkinson, N.H.
About Insulet Corporation
Insulet Corporation, located in Bedford, Massachusetts, is an innovative, privately held, diabetes management company dedicated to providing superior treatment options and lifelong health benefits to people with diabetes. Insulet Corporation employees have extensive experience in the diabetes and medical device industries. Founded in 2000, the company seeks to improve the lives of people with diabetes -- and to break down the barriers to Continuous Subcutaneous Insulin Infusion (CSII) therapy -- through innovative design and technology, and through feedback from people with diabetes, physicians and diabetes educators. http://www.Insulet.com
Source: Insulet Corporation
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.